| Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial YPM Goekoop‐Ruiterman, JK de Vries‐Bouwstra, CF Allaart, ... Arthritis & Rheumatism 52 (11), 3381-3390, 2005 | 1983 | 2005 |
| Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up GM Bartelds, CLM Krieckaert, MT Nurmohamed, PA van Schouwenburg, ... Jama 305 (14), 1460-1468, 2011 | 872 | 2011 |
| Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis GM Bartelds, CA Wijbrandts, MT Nurmohamed, S Stapel, WF Lems, ... Annals of the rheumatic diseases 66 (7), 921-926, 2007 | 699 | 2007 |
| Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis GJ Wolbink, M Vis, W Lems, AE Voskuyl, E De Groot, MT Nurmohamed, ... Arthritis & Rheumatism 54 (3), 711-715, 2006 | 599 | 2006 |
| Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation VP Van Halm, MJL Peters, AE Voskuyl, M Boers, WF Lems, M Visser, ... Annals of the rheumatic diseases 68 (9), 1395-1400, 2009 | 536 | 2009 |
| Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study MJL Peters, VP van Halm, AE Voskuyl, YM Smulders, M Boers, WF Lems, ... Arthritis Care & Research: Official Journal of the American College of …, 2009 | 486 | 2009 |
| Proprioception in knee osteoarthritis: a narrative review J Knoop, MPM Steultjens, M Van der Leeden, M Van der Esch, ... Osteoarthritis and cartilage 19 (4), 381-388, 2011 | 316 | 2011 |
| Joint proprioception, muscle strength, and functional ability in patients with osteoarthritis of the knee M Van der Esch, M Steultjens, J Harlaar, D Knol, W Lems, J Dekker Arthritis Care & Research: Official Journal of the American College of …, 2007 | 296 | 2007 |
| Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study GM Bartelds, CA Wijbrandts, MT Nurmohamed, S Stapel, WF Lems, ... Annals of the rheumatic diseases 69 (5), 817-821, 2010 | 293 | 2010 |
| Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus IEM Bultink, WF Lems, PJ Kostense, BAC Dijkmans, AE Voskuyl Arthritis & Rheumatism 52 (7), 2044-2050, 2005 | 286 | 2005 |
| Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis M Güler-Yüksel, CF Allaart, YPM Goekoop-Ruiterman, ... Annals of the rheumatic diseases 68 (3), 330-336, 2009 | 280* | 2009 |
| Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with … M Vis, EA Havaardsholm, G Haugeberg, T Uhlig, AE Voskuyl, ... Annals of the rheumatic diseases 65 (11), 1495-1499, 2006 | 279 | 2006 |
| Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis–an expert consensus addressing benefits as well as gastrointestinal and cardiovascular … C Scarpignato, A Lanas, C Blandizzi, WF Lems, M Hermann, RH Hunt, ... BMC medicine 13, 1-22, 2015 | 278 | 2015 |
| Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis GJ Wolbink, AE Voskuyl, WF Lems, E De Groot, MT Nurmohamed, PP Tak, ... Annals of the rheumatic diseases 64 (5), 704-707, 2005 | 269 | 2005 |
| Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis RNJ de Nijs, JWG Jacobs, WF Lems, RFJ Laan, A Algra, AM Huisman, ... New England Journal of Medicine 355 (7), 675-684, 2006 | 259 | 2006 |
| The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction PP Geusens, RBM Landewé, P Garnero, D Chen, CR Dunstan, WF Lems, ... Arthritis & Rheumatism 54 (6), 1772-1777, 2006 | 246 | 2006 |
| Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria WE Van Spil, J DeGroot, WF Lems, JCM Oostveen, F Lafeber Osteoarthritis and cartilage 18 (5), 605-612, 2010 | 236 | 2010 |
| Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis PLEM van Lent, AB Blom, RFP Schelbergen, A Slöetjes, FPJG Lafeber, ... Arthritis & Rheumatism 64 (5), 1466-1476, 2012 | 227 | 2012 |
| SCOPE: a scorecard for osteoporosis in Europe JA Kanis, F Borgström, J Compston, K Dreinhöfer, E Nolte, L Jonsson, ... Archives of osteoporosis 8, 1-63, 2013 | 208 | 2013 |
| Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials … RNJ De Nijs, JWG Jacobs, A Algra, WF Lems, JWJ Bijlsma Osteoporosis International 15, 589-602, 2004 | 194 | 2004 |
